Norland's pDexa Bone Densitometer Cleared To Predict Fracture Risk
This article was originally published in The Gray Sheet
Norland Medical Systems gained 510(k) clearance Feb. 9 to market a bone fracture risk assessment feature for its pDexa x-ray bone densitometry system.
You may also be interested in...
Sunlight Ultrasound Technologies plans to pursue FDA approval of multi-site indications for its Omnisense ultrasound bone sonometer following Jan. 20 premarket approval for assessing skeletal fragility along the distal radius (wrist) bone.
Novartis has long championed the idea of making Sandoz an autonomous unit within the Swiss originator while stopping short of carving out the business altogether. Rumors continue to swirl around a potential deal, which was discussed during the recent virtual Meet Novartis Management event.